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Abstract We investigated the distribution patterns of the
extracellular matrix protein Reelin and of crucial Reelin sig-
naling components in murine midbrain and striatum. The
cellular distribution of the Reelin receptors VLDLr and
ApoER2, the intracellular downstream mediator Dab1, and
the alternative Reelin receptor APP were analyzed at embry-
onic day 16, at postnatal stage 15 (P15), and in 3-month-old
mice. Reelin was expressed intracellularly and extracellularly
in midbrain mesencephalic dopaminergic (mDA) neurons of
newborns. In the striatum, Calbindin D-28k+ neurons exhib-
ited Reelin intracellularly at E16 and extracellularly at P15
and 3 months. ApoER2 and VLDLr were expressed in mDA
neurons at E16 and P15 and in oligodendrocytes at 3 months,
whereas Dab1 and APP immunoreactivity was observed in
mDA at all stages analyzed. In the striatum, Calbindin
D-28k+/GAD67+ inhibitory neurons expressed VLDLr,
ApoER2, and Dab1 at P15, but only Dab1 at E16 and
3 months. APP was always expressed in mouse striatum in
which it colocalized with Calbindin D-28k. Our data underline
the importance of Reelin signalling during embryonic devel-
opment and early postnatal maturation of the mesostriatal and
mesocorticolimbic system, and suggest that the striatum and
not the midbrain is the primary source of Reelin for midbrain
neurons. The loss of ApoER2 and VLDLr expression in the
mature midbrain and striatum implies that Reelin functions are
restricted to migratory events and early postnatal maturation
and are dispensable for the maintenance of dopaminergic
neurons.
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Introduction
Reelin is an extracellular matrix protein with crucial roles
during neurodevelopment and adult synaptic plasticity. In
the developing brain, Reelin is produced and secreted by
Cajal-Retzius cells that reside in the marginal zone (Del Río
et al. 1997) and regulates normal migration and the formation
of laminar brain structures including the cortex, hippocampus,
and cerebellum (D’Arcangelo et al. 1999; Hiesberger et al.
1999; Curran and D’Arcangelo 1998; Tissir and Goffinet
2003; Förster et al. 2006). Reelin is localized in specific
neuronal populations (Lacor et al. 2000) in both adult and
embryonic rodent brains and exerts its effects through binding
to apolipoprotein E receptor type 2 (ApoER2) and very low
density lipoprotein receptors (VLDLr; Jossin et al. 2004;
D’Arcangelo et al. 1997, 1999; Morimura et al. 2005). Bind-
ing of Reelin to these receptors causes clustering of the recep-
tors and the activation of tyrosine kinase, which in turn phos-
phorylates the cytoplasmic disabled adaptor protein (Dab1;
D’Arcangelo et al. 1999; Hiesberger et al. 1999). Upon
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phosphorylation of Dab1, Src-family tyrosine kinases and
other non-receptor tyrosine kinases become activated and
trigger multiple downstream signaling cascades (Arnaud
et al. 2003; Jossin et al. 2003; Howell et al. 1999), ultimately
leading to the regulation of neuronal migration and
neurite outgrowth (Del Río et al. 1997; Borrell et al.
1999; Niu et al. 2004; Beffert et al. 2005; Hiesberger
et al. 1999; Arnaud et al. 2003).
Disruptions of the Reelin signaling pathway lead to severe
motor deficits. Mice deficient for Dab1 and for both ApoER2/
VLDLr display the same migratory phenotypes and are sim-
ilar to reeler mice (Sharaf et al. 2013; Herz and Bock 2002;
Trommsdorff et al. 1999). The migratory deficits in reeler
mice might be attributable to the direct effect of Reelin on
the neurons and/or on the differentiation of radial glia cells,
which have an important role in controlling neuronal migra-
tion (Förster et al. 2002). In addition, Reelin- and Dab1-
deficient mice show deficits in the normal migration of mes-
encephalic dopaminergic neurons (mDA; Kang et al. 2010)
and hindbrain motor neurons (Rossel et al. 2005).
In the mature brain, numerous studies have demonstrated
the role of Reelin in synaptic plasticity. Accordingly,
ApoER2, VLDLr, and Dab1 remain expressed in the adult
brain. Interestingly, Reelin can also bind to other transmem-
brane protein receptors, including amyloid beta precursor
proteins (APP) in vivo and in vitro (Hoe et al. 2009). The
biological significance of the Reelin/APP interaction is not yet
elucidated but, during the last few years, accumulating
evidence has suggested the involvement of Reelin in the
pathogenesis of Alzheimer’s disease. Reelin is indeed down-
regulated in APP-overexpressing mice but is upregulated in
APP-deficient mice (Hoe et al. 2009).
mDA neurons are divided into three subpopulations: the
substantia nigra pars compacta (SNpc; A9), the ventral teg-
mental area (VTA; A10), and the retrorubral field (RrF; A8).
With regard to their connectivity and morphology, mDA
neurons can be separated into two subpopulations: the
calbindin-expressing mDA neurons that innervate ventral
striatal, limbic, and cortical areas, and the GIRK2-positive
(GIRK2+) mDA neurons that project to the striatum
(Björklund and Dunnett 2007).
We have previously described the roles of ApoER2 and
VLDLr in the proper migration and positioning of mouse
mDA neurons (Sharaf et al. 2013). VLDLr- and ApoER2-
mutant mice exhibit both a reduction in and abnormal posi-
tioning of mDA neurons, and ApoER2/VLDLr double-
knockout mice show a phenotype comparable with the phe-
notypes observed for Reelin- and Dab1-mutant mice, demon-
strating the essential roles of ApoER2 and VLDLr in the
Reelin-mediated migration and positioning of mDA neurons.
However, the presence and distribution of Reelin signaling
components in the mature dopaminergic system has not yet
been addressed. In the present study, we have investigated the
distribution patterns of Reelin signaling pathway components
in the murine midbrain and striatum during embryonic, post-
natal, and adult stages.
Materials and methods
Experimental animals
This study was carried out in strict accordance with national
health and ethical regulations, and the care of animals was in
accordance with institutional guidelines. The protocol was
approved by the Committee on the Ethics of Animal Experi-
ments of Freiburg University. Mice were studied at embryonic
(E16), postnatal (P0-P15), and adult stages (3 months old).
Pregnant mice were killed by cervical translocation, embryos
were collected, and brains were immediately dissected and
immersion-fixed in a 4 % paraformaldehyde (PFA) solution.
Mice at postnatal ages were anesthetized by using 10 %
ketamin (20 mg/kg, Pfizer) and 2 % Rumpon (4 mg/kg, Bayer
Healthcare) and transcardially perfused with a freshly pre-
pared 4 % PFA solution in phosphate-buffered saline (PBS,
pH 7.2; Merck, Germany). Following perfusion, the brains
were dissected and postfixed in 4 % PFA for at least 24 h.
Immunohistochemistry
Mouse brains were fixed in 4 % PFA overnight, followed by
fixation in Bouin’s solution for 4 h, and were subsequently
embedded in paraffin. Midbrain and striatum were then cut
into coronal serial sections (10 μm). For immunohistochem-
istry, sections were deparaffinized, rehydrated with descend-
ing grades of ethanol, and washed with PBS. Antigen retrieval
was carried out in 0.1 M citrate buffer (pH 6) for 10 min by
using a microwave oven (600 W). Sections were incubated
with 10 % H202 in methanol for 15 min to block endogenous
peroxidase activity in the tissue. They were then blocked by
using PBS containing 10 % normal goat serum (NGS; Life
Technologies, Germany) and 10 % Triton X-100 (Sigma,
Germany) to minimize nonspecific labeling, incubated with
primary antibodies diluted in blocking solution overnight at
4 °C, incubated for 1 h in PBS containing biotinylated goat
anti-mouse secondary antibody (1:300; Molecular Probes),
washed in PBS, and incubated with an Avidin-Biotin complex
(ABC, Vector Labs) for 1 h. Peroxidase reaction products
were visualized by using a peroxidase substrate kit (SK
4700, Vector labs) for 10 min as described by Adams
(1981). For double-immunohistochemistry, sections were sub-
sequently incubated with goat anti-rabbit IgG conjugated with
alkaline phosphatase (1:300; Molecular Probes) for 1 h at
room temperature. The alkaline phosphatase reaction was
visualized by incubation with fast red tablets (Roche, Germa-
ny) dissolved in 0.1 M TRIS-HCl (pH 8.2) for 10–30 min.
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Sections stained with peroxidase were dehydrated with as-
cending grades of ethanol, cleared with xylene, and
coverslipped by using an Entellan mounting medium (Merck,
Germany). Sections labeled with alkaline phosphatase were
mounted with Aquatex (Merck, Germany).
Double-immunofluorescence
For double-immunofluorescence, sections were treated as
above and incubated with the primary antibodies in
blocking solution overnight at 4 °C. Subsequently, sec-
tions were washed in PBS and incubated with goat anti-
mouse Alexa Fluor 568 (1:500) and goat anti-rabbit Alexa
Fluor 488 (1:500) secondary antibodies (Molecular
Probes) for 1 h at room temperature. Sections were
washed with PBS and mounted with Fluoromount-G.
Slides were then observed under an epifluorescence mi-
croscope (Zeiss Axioplan 2, Jena, Germany). Confocal
images were captured by using the Leica SP8 confocal
imaging system (Leica, Wetzlar, Germany).
Overview of primary antibodies
The specificity of Reelin, ApoER2, VLDLr, and Dab1 anti-
bodies had previously been tested on brain tissue from mutant
mice, and the optimal antibody dilution was individually
determined for each antibody. A list of the primary antibodies
used in the present study is shown in Table 1.
Results
Expression of reelin in mouse midbrain and striatum
To elucidate the expression patterns of Reelin and its signaling
components, including the transmembrane receptors
VLDLr, ApoER2, APP, and the cytoplasmic Dab1, in
the mouse midbrain and striatum, immunohistochemical
studies on coronal brain sections from E16 to 3 months
were performed. In order to confirm the specificity of
the Reelin antibody, brain sections obtained from
Reelin-deficient mice were used as a negative control;
no Reelin was detected (data not shown). As demon-
strated in Fig. 1a–c, Reelin was not expressed by neu-
rons postive for tyrosine hydroxylase (TH) in the mid-
brain at E16. Similar results were obtained in midbrain
samples from P15 and 3-month-old mice. Whereas no
intracellular Reelin signal was detectable at P15
(Fig. 1d–f) and 3 months (Fig.1g–i), extracellular im-
munoreactivity for Reelin was observed. Interestingly, at
P0, distinct Reelin positivity was detected in the cyto-
plasm of midbrain neurons and in the adjacent extracel-
lular space (Fig. 1j–o) indicating that Reelin expression
in the midbrain was restricted to a relatively small time
period, and that Reelin was afterwards stored in extra-
cellular pools. Figure 1p–r demonstrates that TH+ mid-
brain neurons at 3 months show virtually no Reelin
positivity. However, a distinct Reelin immunoreactivity
could be observed in the extracellular space surrounding
TH+ neurons.
Table 1 List of primary antibodies used (VLDLr very low density
lipoprotein receptor, ApoER2 apolipoprotein E receptor type 2, APP
amyloid beta precursor protein,GAD glutamic acid decarboxylase, NeuN
neuronal nuclear antigen, TH tyrosine hydroxylase, Dab1 disabled adap-
tor protein, GFAP glial fibrillary acidic protein)
Antibody name Company Dilution
Anti-Reelin (mouse) Millipore (MAB5364) 1:300
Anti-VLDLr (rabbit) Santa Cruz Biotechnology (sc-20745) 1:100
Anti-ApoER2 (rabbit) Santa Cruz Biotechnology (sc-20746) 1:100
Anti-APP (mouse) Millipore (MAB348) 1:100
Anti-GAD67 (mouse) Millipore(MAB5406) 1:500
Anti-Calbindin D-28k (rabbit) Millipore (AB1778) 1:500
Anti-Calbindin D-28k (mouse) Sigma-Aldrich (C9848) 1:500
Anti-NeuN (mouse) Millipore (MAB377) 1:200
Anti-TH (rabbit) Millipore (AB152) 1:1000
Anti-TH (mouse) Millipore (MAB318) 1:1000
Anti-Dab1 (mouse) Provided by Dr. Hans Bock, Klinik for
Gastroenterology, University of Duesseldorf
1:500
Anti-Dab1 (rabbit) Abcam (ab111684) 1:500
Anti-GFAP (mouse) Millipore (MAB3402) 1:500
Anti-Olig2 (rabbit) Millipore (AB9610) 1:300
Tomatolectin-fluorescein-isothiocyanate Sigma-Aldrich (L0401-1MG) 1:200
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Analysis of Reelin expression in the striatum at E16,
P15, and 3 months revealed strong Reelin immunoreac-
tivity at all time points examined. At E16, Reelin was
found to be located in the cytoplasm of striatal neurons
(Fig. 2a–c), most of which were positive for Calbindin
D-28k, a marker for inhibitory spiny neurons. At P15, a
similar expression pattern of Reelin was observed
(Fig. 2d–f); however, only some spiny interneurons
(Calbindin D-28k+) displayed cytoplasmic Reelin stain-
ing (asterisks in Fig. 2d–i). Interestingly, Reelin immu-
noreactivity was further found in the extracellular space
surrounding striatal neurons (Fig. 2g–i). Analysis of
striatal sections from 3-month-old mice showed strong
Reelin positivity that was mainly located extracellularly
(Fig. 2j–o). Only weak intracellular Reelin labeling was
detected in Calbindin D-28k+ neurons (asterisks in
Fig. 2j–o). These results demonstrate that robust Reelin
expression is present in the striatum at various developmental
stages ranging from E16 to 3 months. Although, at P0, distinct
expression of Reelin is detectable in the midbrain, our results
suggest that the main sources of Reelin are the striatal inhib-
itory neurons.
VLDLr localization in mouse midbrain and striatum
To examine further the localization pattern of VLDLr
receptors in midbrain mDA neurons and in the striatum,
we conducted double-immunofluorescence staining by
using a rabbit polyclonal antibody specific to the
amino-terminal domains of VLDLr at various embryonic
and postnatal stages. As shown in Fig. 3a–f, VLDLr
expression was found in TH+ mDA neurons and to a
lesser extent in adjacent neuron populations. At
3 months, TH+ neurons showed no positivity for
VLDLr, whereas several small-sized cells in close prox-
imity to TH+ neurons displayed strong VLDLr signals
(Fig. 3g–i). In order to identify these cells, we used
several cellular markers. Figure 3j–l demonstrates that
VLDLr was not expressed by midbrain neurons (posi-
tive for neuronal nuclear antigen [NeuN+]) at 3 months.
Moreover, no glial fibrillary acidic protein (GFAP)+
astrocytes (Fig. 3m–o), Tomatolectin+ microglia, or en-
dothelial cells (Fig. 3p–r) were positive for VLDLr.
Using VLDLr in combination with Olig2 as a marker
for oligodendrocytes, we were able to show that oligo-
dendroglia cells express VLDLr in midbrains of 3-
month-old mice (Fig. 3s–u).
Analysis of VLDLr expression in the striatum revealed
virtually no expression at E16, strong expression at P15, and
intense expression that was restricted to a small subset
of cells at 3 months (Fig. 4a–c). Figure 4d–f clearly
demonstrates that several NeuN+ striatal neurons did not
express VLDLr at 3 months. Further, GFAP+ astrocytes
(Fig. 4g–i) and Tomatolectin+ microglia (Fig. 4j–l) were
not VLDLr+ at 3 months. As described for the mid-
brain, Olig2+ oligodendroglia showed strong immunore-
activity for VLDLr, demonstrating that the oligoden-
droglia are the cell population expressing VLDLr in
the striatum at 3 months of age (Fig. 4m–o).
In order to identify the neuronal subpopulation that
expresses VLDLr in the striatum, double-labeling for
VLDLr and Calbindin D-28k was performed at E16,
P15, and 3 months. As shown in Fig. 5, striatal
Calbindin D-28k+ neurons only expressed VLDLr at
P15 (Fig. 5d–f). No VLDLr expression was detectable
at E16 (Fig. 5a–c), and at 3 months (Fig. 5g–i), VLDLr
expression occurred neither in Calbindin D-28k+ neu-
rons nor in any other neuron population.
Taken together, these results demonstrate that the expres-
sion of VLDLr was present at early postnatal stages in mDA
midbrain neurons and in Calbindin D-28k+ striatal inhibitory
neurons. At 3 months, VLDLr expression is restricted to
oligodendrocytes.
ApoER2 expression in murine midbrain and striatum
The expression of the Reelin receptor ApoER2 was
analyzed at E16, P15, and 3 months in the midbrain
(Fig. 6). At E16, virtually all TH+ midbrain neurons
were positive for ApoER2 (Fig. 6a–c). Analysis of
TH+ neurons from the substantia nigra revealed that
all mDA neurons expressed ApoER2 at P15 (asterisks
in Fig. 6d–f). However, several cells not labeled by TH-
immunostaining (Fig. 6e, arrowheads) displayed strong
ApoER2 immunoreactivity (Fig. 6d, f). Interestingly, no
ApoER2 expression was detectable in the midbrain at
3 months of age (Fig. 6g–i).
Analysis of ApoER2 expression in the striatum at
E16, P15, and 3 months revealed that ApoER2
Fig. 1 Reelin distribution pattern in mouse midbrain. a–l Double-
immunofluorescence for tyrosine hydroxylase (TH) and Reelin in
substantia nigra neurons at embryonic day 16 (E16; a–c), at postnatal
day 15 (P15; d–f), in newborn (P0; j–l), and in 3-month-old mice (g–i).
At E16 (a–c), Reelin immunolabeling cannot be detected in dopaminergic
neurons. At P15 (d-f) and in 3-month-old mice (g–i), mesencephalic
dopaminergic (mDA) neurons of the substantia nigra are devoid of
Reelin immunoreactivity (Reelin-ir). However, weak extracellular
Reelin immunoreactivity is observed at P15 and 3 months. In newborn
mice (P0), TH (j) and Reelin (k) are co-localized, demonstrating that
midbrain neurons (asterisks) exhibit an intracellular Reelin distribution.
Confocal images demonstrate intracellular (arrowheads) Reelin signals in
TH+ midbrain mDA neurons and an extracellular Reelin localizationm–
o. At 3 months, Reelin immunoreactivity is present extracellularly,
whereas TH+ neurons (arrowheads) show no intracellular Reelin
signals (p–r). Bars 50 μm (a–l), 10 μm (m–r)
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immunoreactivity was present at P15 (Fig. 7g–l). At
E16 (Fig. 7a–f) and 3 months (Fig. 7m–r), no ApoER2
signal was observed. Using Calbindin D-28k (Fig. 7h, i)
and GAD67 (Fig. 7k, l) as markers for inhibitory striatal
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interneurons, we were able to show that ApoER2 was
expressed by these striatal neuron populations. Notably,
GAD67+ striatal neurons showed a stronger ApoER2
signal. However, some neurons expressing ApoER2
were not positive for the abovementioned markers and,
thus, represented another striatal neuron population.
Using acetylcholinesterase as a marker, we were able
to identify these cells as cholinergic interneurons (data
not shown). Together, these data indicate that the ex-
pression of ApoER2 in midbrain and striatum is restrict-
ed to early postnatal stages and is no longer observed in
the mature mesostriatal and mesocorticolimbic system.
Dab1 expression in mouse midbrain and striatum
Dab1, the essential intracellular downstream mediator for
Reelin signaling, was expressed by TH+ midbrain neu-
rons at E16 (Fig. 8a–c), P15 (Fig. 8d–f), and to a
lesser extent, 3 months (Fig. 8g–i). However, TH+
neurons were not the only cell population expressing
Dab1, since several neurons in close proximity to TH+
neurons also showed clear immunoreactivity for Dab1,
which was most pronounced at 3 months (Fig. 8g–i).
Moreover, TH+ neurons expressed Dab1 at different
levels. Especially at P15, we identified TH+ neurons
Fig. 2 Reelin distribution pattern
in mouse striatum. Double-
immunofluorescence for
Calbindin D-28k and Reelin in
mouse striatum at E16 (a–c), at
P15 (d–i), and in 3-month-old
mice (j–o). At E16, Calbindin
D-28k and Reelin co-localize in
the cytoplasm in virtually all cells.






D-28k+) neurons (asterisks) and
Calbindin D-28k-negative
neurons (arrowheads) still show
cytoplasmic Reelin
immunoreactivity (g–i). At
3 months, Calbindin D-28k+
neurons (asterisks) show weak
intracellular Reelin
immunoreactivity (j–o).
Moreover, Reelin is deposited
extracellularly, and Calbindin
D-28k-negative neurons
(arrowheads) display virtually no
Reelin immunoreactivity (m–o).
Bars 20μm (a–f, j–l), 10μm (g–
i, m–o)
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Fig. 3 Very low density
lipoprotein receptor (VLDLr)
distribution pattern in mouse
midbrain in embryonic, postnatal,
and adult stages. a–c Double-
immunofluorescence for the
dopaminergic marker TH (a) and
VLDRr (b) in fixed midbrain
sections of mouse at E16. Overlay
(c) illustrates expression of
VLDLr in dopaminergic neurons.
d–f Double-immunofluorescence
for TH (d) and VLDRr (e) in
substantia nigra at P15 reveals co-
localization of the proteins (f). g–i
In 3-month-old mice, although
VLDLr immunoreactivity is
present in ventral midbrain (h),
dopaminergic neurons are devoid
of VLDLr expression (i). j–u
Characterization of midbrain cells
expressing VLDLr in 3-month-
old mice. Double-
immunofluorescence for VLDLr
and neuronal nuclear antigen
(NeuN; j–l), the astrocyte marker
glial fibrillary acidic protein
(GFAP; m–o), or Tomatolectin
(p–r) reveals that VLDLr is not
colocalized with these proteins. s,
t Overviews of double
immunohistochemistry for
VLDRr and oligodendrocyte
marker Olig2. t Co-localization of
VLDLr and Olig2 proteins. u
Higher magnification of white
boxed area in t illustrating nuclear
Olig2 labeling (asterisks) and
intracellular VLDLr labeling
(arrowheads). Bars 100 μm (s),
50 μm (a–i, t), 20 μm (j–r, u)
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with high Dab1 expression (asterisks in Fig. 8d–f) and
neurons with low Dab1 expression (arrowheads in
Fig. 8d–f). Analysis of Dab1 expression in the striatum at
E16 (Fig. 8j–l), P15 (Fig. 8m–o), and 3 months (Fig. 8p–r)
revealed that Dab1 was expressed at all time points analyzed.
Using GAD67 as a marker, we were able to demonstrate that
GABAergic interneurons expressed Dab1 (Fig. 8l, o, r). These
data demonstrate that Dab1 shows a more distinct expression
pattern in midbrain and striatum than the Reelin receptors
VLDLr and ApoER2.
APP expression in the mouse midbrain and striatum
APP, which is related to the LDL family of proteins
(Siemes et al. 2006; Young-Pearse et al. 2007; Hoareau
et al. 2008), has been shown to be an alternative recep-
tor for Reelin (Hoe et al. 2009). Therefore, we further
analyzed the expression pattern of APP in the murine mid-
brain and striatum at E16, P15, and 3 months. As depicted by
Fig. 9, APP immunoreactivity was observed at E16 (Fig. 9a–
c), P15 (Fig. 9d–f), and 3 months (Fig. 9g–i) and was
Fig. 4 Localization of VLDLr in
mouse striatum in embryonic,
postnatal, and adult stages. a–c at
E16 (a), no VLDLr
immunoreactivity is detected,
whereas at P15 (b), VLDLr
expression is prominent and
declines again at 3 months (c). d-o
Identification of striatal cells
expressing VLDLr at 3 months.
Double-immunofluorescence
with NeuN (d–f), GFAP (g–i),
and Tomatolectin (j–l) illustrates
no colocalization of the proteins.
m–o Double-
immunohistochemistry for the
oligodendrocyte marker Olig 2
and VLDLr reveals co-expression
of the proteins. o Higher
magnification of the white boxed
area in n. Strong intracellular
VLDLr labeling (arrowhead) is
shown in Olig2-expressing cells
(asterisk). Bars 100 μm (m),
50 μm (a–c, n), 20 μm (d–l, o)
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Fig. 5 Identification of striatal
cells expressing VLDLr. Double-
immunofluorescence for VLDLr
and Calbindin D-28k. At E16 (a–
c), VLDL-r expression is absent
in mouse striatum. At P15 (d–f),
striatal Calbindin D-28k+ cells
also express VLDLr. At 3 months
(g–i), no colocalization is
observed between Calbindin
D-28k and VLDL. Bar 50 μm
Fig. 6 Apolipoprotein E receptor
type 2 (ApoER2) distribution
pattern in mouse midbrain in
embryonic, postnatal, and adult
stages. Double-
immunofluorescence for the
dopaminergic marker TH and
ApoER2 on fixed midbrain
sections of mouse at E16 (a–c), at
P15 (d–f), and in 3-month-old
mice (g–i). At E16, mDA neurons
express ApoER2 (overlay in c).
At P15 (d–f), TH-
immunoreactive neurons of the
substantia nigra also reveal
ApoER2 immunoreactivity
(asterisks a cell that exhibits both
TH and ApoER2
immunolabeling, arrowheads
cells positive for ApoER2 but
negative for TH). In 3-month-old
mice (g–i), no ApoER2
immunoreactivity was detectable
in midbrain. Bars 50 μm
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predominantly found in TH+ midbrain neurons. Overlay im-
ages (Fig. 9c, f, i) suggest that only a subset of TH+ neurons
expressed APP. However, this impression was attributable to
the different expression levels of APP as indicated by the
Fig. 7 Localization of ApoER2
in mouse striatum in embryonic,
postnatal, and adult stages.
Double-immunofluorescence for
ApoER2 with Calbindin D-28k
and glutamic acid decarboxylase
67 (GAD67) at E16 (a–f), at P15
(g–l), and 3 months (m–r).
Overlays for ApoER2 and
Calbindin D-28k reveal that
Calbindin D-28k-
immunopositive cells are devoid
of ApoER2 at E16 and at
3 months. In contrast, at P15, both
Calbindin D-28k+ neurons and
other cells express ApoER2 (i).
Overlays for ApoER2 and
GAD67 reveal that GAD67-
immunopositive cells are devoid
of ApoER2 at E16 (f) and at
3 months (r). In contrast, at P15, a
subset of ApoER2-
immunoreactive cells also express
GAD67 (l). Bars 50 μm
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asterisks (high APP expression) and arrowheads (low APP
expression) in Fig. 9d–i. Analysis of APP expression in the
striatum revealed APP immunoreactivity at E16 (Fig. 9j–l),
P15 (Fig. 9m–o), and 3 months (Fig. 9p–r). Using Calbindin
Fig. 8 Disabled adaptor protein
(Dab1) distribution pattern in
mouse midbrain and striatum in
embryonic, postnatal, and adult
stages. a–i Double-
immunofluorescence for Dab1
and TH in mouse midbrain at E16
(a–c), P15 (d–f), and 3 months
(g–i) Overlays c, f, i illustrate
Dab1 expression in dopaminergic
neurons at E16, P15, and
3 months (asterisks TH+ neuron
with high Dab1 expression,
arrowheads TH+ neuron with low
Dab1 expression). In mouse
striatum j–r), Dab1
immunoreactivity is observed at
E16 (j–l), P15 (m–o), and
3 months (p–r) and is co-
localized with GAD67. Bars
50 μm
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D-28k as a marker, we were able to demonstrate that striatal
inhibitory neurons robustly expressed APP at all time points
analyzed (Fig. 9l, o, r).
In summary, TH+ midbrain neurons and striatal inhibitory
neurons express APP from embryonic stages into adulthood,
further suggesting a role for APP in the mesostriatal and
Fig. 9 Amyloid beta precursor
protein (APP) distribution pattern
inmouse midbrain and striatum in
embryonic, postnatal, and adult
stages. Double-
immunofluorescence for APP and
TH in mouse midbrain at E16 (a–
c), P15 (d–f), and 3 months (g–i).
Overlays c, f, i illustrate APP
expression in dopaminergic
neurons at E16, P15, and
3 months (asterisks TH+ neuron
with high APP expression,
arrowheads TH+ neuron with low
APP expression). In mouse
striatum (j–r), APP abundance is
prominent at E16 (l) and declines
at P15 (o) and at 3 months (r).
Double-immunofluorescence
reveals colocalization of APP
with Calbindin D-28k. Bars
50 μm
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mesocorticolimbic system extending beyond develop-
mental processes.
Discussion
In the present study, we have elucidated the temporal and
spatial expression patterns of Reelin and its signaling recep-
tors VLDLr and ApoER2. Moreover, we have further ana-
lyzed the expression of the intracellular downstream mediator
Dab1 and the alternative Reelin receptor APP in the murine
midbrain and striatum. The development of mDA neurons is a
complex process that involves the early specification and
phenotype induction of this neuron population plus the essen-
tial migration event of young mDA neurons to give rise to the
anatomical specified midbrain regions VTA and SN. Newborn
TH+ neurons of the midbrain, which later become SN neu-
rons, have to migrate from the ventral floor in a radial manner
and must further migrate tangentially to be positioned laterally
in the SN pars compacta (Smidt and Burbach 2007). The
initial evidence for a functional role of Reelin during the
migration of SN neurons was presented by Nishikawa and
colleagues (2003). The authors demonstrated that Reelin mu-
tant mice showed an accumulation of SN neurons lateral to the
VTA because of a migration failure of these neurons. Interest-
ingly, the fiber projections of the misplaced mDA neurons
were not impaired, and the proper innervation of the striatum
was observed. A similar migratory phenotype of mDA neu-
rons, which are destined to become SN neurons, has also been
described in ApoER2−/−, VLDLr−/−, and ApoER2/VLDLr
double-mutant mice and in mice lacking the intracellular
Reelin downstream mediator Dab1 (Sharaf et al. 2013; Kang
et al. 2010). These studies clearly demonstrate the important
roles of Reelin and its signaling components in the migration
and proper positioning of the mDA neurons of the SN. How-
ever, a detailed analysis of the expression patterns of Reelin
and its receptors in the mouse midbrain and striatum has, until
now, been missing. Here, we describe the expression patterns
of Reelin, VLDLr, ApoER2, Dab1, and APP in the mouse
midbrain and striatum at E16, P15, and 3 months of age. We
have clearly demonstrated that the Reelin receptors ApoER2
and VLDLr are expressed by TH+ midbrain neurons at E16
and P15 but not at 3 months. The expression pattern of the
aforementioned Reelin signaling components in the striatum
is different. At P15, Calbindin D-28k+/GAD67+ inhibitory
spiny neurons express ApoER2 and VLDLr. Interestingly,
no expression of ApoER2 and VLDLr is observed in striatal
neurons at E16 or 3 months. Notably, the expression of
VLDLr in the midbrain and striatum at 3 months is restricted
to the oligodendrocytes and is no longer detectable in neurons.
Myelinating oligodendrocytes have been reported to express
LDLr and VLDLr selectively in the postnatal spinal cord at P7
and P15 (Zhao et al. 2007), and the VLDLr+ oligodendrocytes
observed in both midbrain and striatum might also be in-
volved in myelination processes.
The temporal expression patterns of ApoER2 and VLDLr
underline the importance of Reelin signaling during embry-
onic development and the early postnatal maturation of the
mesostriatal and mesocorticolimbic system und further sug-
gest that Reelin signaling is not involved in promoting the
maintenance and survival of TH+ neurons in the mature sys-
tem. Studies of mice mutant for Reelin receptors further
support this hypothesis, since none of the mutants analyzed
show any substantial loss of midbrain TH+ neurons. The
reduced numbers of TH+ neurons in the SN of these mutants
arises because of a lack of migration and the subsequent
clustering of SN neurons at the lateral border of the VTA. A
reduction in total numbers of midbrain TH+ neurons has not
been detected (Kang et al. 2010; Sharaf et al. 2013). These
data provide evidence that Reelin signaling is dispensable for
neuron survival but indispensable for the migration and posi-
tioning of TH+ neurons of the SN, as is further supported by a
recent study by Bodea and colleagues (2014). The authors
have demonstrated that the distinct migratory pathways taken
by VTA and SN neurons are determined by specific signaling
pathways. Whereas exclusively radially migrating VTA neu-
rons require CXCR4/CXCL12 signaling, tangentially migrat-
ing SN neurons are dependent on ApoER2/VLDLr/Reelin
signaling. The finding that Dab1−/− mice show the same
phenotype as the mice mutant for Reelin receptors indicates
the importance of Dab1 as the essential intracellular down-
stream mediator of Reelin signals (Kang et al. 2010; Sharaf
et al. 2013). Notably, we have observed a level of Dab1
expression that exceeds that of ApoER2 and VLDLr. At
3 months, Dab1 is detectable in TH+ neurons and in
GAD67+ striatal neurons. This expression pattern is similar
to the pattern observed for the alternative Reelin receptor APP,
which shows strong expression in TH+ neurons and striatal
neurons at 3 months. Interestingly, APP has been demonstrat-
ed to be able to interact with and activate Dab1 (Homayouni
et al. 1999). The functional significance of these interactions is
unclear, but we have to take into account that Dab1 might also
be involved in pathways independent of Reelin. A contribu-
tion to neurodegenerative processes in the mesostriatal and
mesocorticolimbic system should be considered, especially in
the context of the APP-Dab1 axis. Mice lacking APP have
been shown to develop attenuated degeneration of mDA
neurons following the axotomy of the medial forebrain bundle
(DeGiorgio et al. 2002a) accompanied by decreased microglia
activation and enhanced neuron survival (DeGiorgio
et al. 2002b).
In the present study, we have further addressed the expres-
sion of Reelin in the mouse midbrain and striatum at E16, P15,
and 3 months. Distinct Reelin expression in midbrain neurons
could only be detected at P0, and extremely weak Reelin
Cell Tissue Res (2015) 359:393–407 405
immunoreactivity was observed at 3 months. However, in the
striatum, we could observe continuous Reelin expression from
E16 to 3 months. Interestingly, Reelin was predominantly
located intracellularly at E16 and could be detected intracel-
lularly and extracellularly at P15. Moreover, at 3 months,
Reelin was barely detectable in the cytoplasm of striatal
neurons and seemed to be predominantly located extracellu-
larly. These results suggest that the striatum and not the
midbrain is the primary source of Reelin for midbrain neurons,
and that Reelin is transported retrogradely via fibers of TH+
neurons. However, Nishikawa and colleagues (2003) have
demonstrated that anterograde Reelin transport via the axonal
projections of embryonic striatal neurons takes place. To
our knowledge, a retrograde transport of Reelin from
the striatum to the midbrain by mDA neurons has not
as yet been shown. Thus, we need to establish whether
retrograde transport of Reelin via dopaminergic axons
takes place and is involved in the Reelin-mediated po-
sitioning of TH+ neurons.
Taken together, the observed expression patterns of Reelin
and its signaling components in the embryonic and postnatal
midbrain and striatum presented in the present study reflect
the importance of the Reelin signaling pathway during em-
bryonic and early postnatal development. The loss of ApoER2
and VLDLr expression in the mature midbrain and striatum
demonstrates that Reelin functions are restricted to migratory
events and early postnatal maturation and are dispensable for
the maintenance of TH+ neurons. The expression pattern data
presented in this study provide the basis for an understanding
of Reelin signaling-mediated mechanisms during the migra-
tion of the TH+ neurons of the mesostriatal and
mesocorticolimbic system.
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